Previous Section | Index | Home Page |
9 Mar 2010 : Column 190Wcontinued
Mr. Burrowes: To ask the Secretary of State for Health how many newborn babies experienced methadone withdrawal in the latest period for which figures are available; and what treatments are used in the NHS for the symptoms of withdrawal. [321304]
Gillian Merron: Data on the number of babies born with neonatal withdrawal symptoms from maternal use of illicit or therapeutic drugs are collected, but are not broken down by type of drug.
In 2008-09, 1,233 babies were born with neonatal withdrawal symptoms from maternal use of illicit or therapeutic drugs.(1)
The Department and the National Treatment Agency for Substance Misuse have issued guidance to the national health service to ensure that mothers in this situation are supported and monitored, and the health needs of the baby assessed to minimise any health risks.
Additionally, the National Institute for Health and Clinical Excellence is in the process of producing clinical guidelines for pregnant women with complex social factors, including substance misuse problems.
Source:
(1) Hospital Episode Statistics, The Information Centre for health and social care
Mr. Stephen O'Brien: To ask the Secretary of State for Health (1) how many (a) E112 authorisations and (b) Article 49 authorisations for each type of treatment there have been in each year since 1998; [319931]
(2) how many patients have been referred abroad for each treatment in respect of which there were no facilities in the UK in each year since 1998. [319934]
Gillian Merron: A patient may be issued an E112 form and referred to another member state of the European Economic Area or Switzerland for treatment, if they would experience undue delay for that same treatment under their state health care system.
Alternatively, a patient may choose to access health care services in another member state under article 49 (now article 56 of the Lisbon treaty). The responsibility for authorising reimbursement of health costs under article 49 is devolved to primary care trusts, and there is no central collection of the data.
The following table shows the number of E112s, and the number of those that relate to maternity care, issued by the United Kingdom in the years 1998-2009. Member states have agreed that it is appropriate to issue the form E112 on a discretionary basis to expectant mothers who wish to give birth in another member state, regardless of capacity. Data relating to each specific treatment are held centrally, however to process the data and present them by treatment type would incur disproportionate cost.
Calendar year | E112s issued | Number of E112s relating to maternity care |
Mr. Lansley: To ask the Secretary of State for Health if he will place in the Library a copy of each item of correspondence received by his Department from the Healthcare Commission on the Mid Staffordshire General Hospitals NHS Trust in (a) 2006, (b) 2007 and (c) 2008. [320782]
Mr. Mike O'Brien: The information could be obtained only at disproportionate cost.
Mr. Lansley: To ask the Secretary of State for Health how many full-time equivalent midwives were working in the NHS organisation in each year since 1997; and how many were working in each NHS organisation in each of the last three years. [320920]
Ann Keen: The following table shows the number of full-time equivalent midwives employed within the national health service in each year since 1997 and a separate table outlining the number of midwives working in each NHS organisation in each of the last three years has been placed in the Library.
NHS hospital and community health services: Qualified midwifery staff in England as at 30 September each specified year | |
Registered midwives | Full-time equivalent |
Source: The NHS Information Centre for health and social care Non-Medical Workforce Census |
Nick Harvey: To ask the Secretary of State for Health how many patient deaths have been caused by myelodysplastic syndromes in each year for which figures are available. [321379]
Angela E. Smith: I have been asked to reply.
The information requested falls within the responsibility of the UK Statistics Authority. I have asked the authority to reply.
Letter from Stephen Penneck, dated March 2010:
As Director General for the Office for National Statistics, I have been asked to reply to your recent question asking how many patient deaths have be caused by myelodysplastic syndromes in each year for which figures are available. (321379)
The table attached provides the number of deaths where the underlying cause was myelodysplastic syndromes in England and Wales, for the years 2001 to 2008 (the latest year available).
It is not possible from the information given at death registration to state whether the deceased was a patient at the time of death.
Individual causes of death are coded by ONS using the International Classification of Diseases, Tenth Revision (ICD-10). Myelodyplastic syndromes are given a specific ICD-10 code (D46), however equivalent information is not readily available for years before 2001, when an earlier version of the International Classification of Diseases was in use.
Table 1. Number of deaths where the underlying cause was myelodysplastic syndromes, England and Wales, 2001-08( 1, 2, 3) | |
Deaths (persons) | |
(1) Cause of death was defined using the International Classification of Diseases, Tenth Revision (ICD-10) code D46 'Myelodysplastic syndromes'. (2) Figures for England and Wales include deaths of non-residents. (3) Figures are for deaths registered in each calendar year. |
Nick Harvey: To ask the Secretary of State for Health how many individual funding requests for the drug azacitidine were received by primary care trusts in the last 12 months; and how many were (a) accepted and (b) rejected. [321380]
Mr. Mike O'Brien: This information is not collected centrally.
Mr. Lansley: To ask the Secretary of State for Health what account his Department takes of mortality rates at NHS trusts when deciding whether trusts' applications for foundation status can proceed to Monitor. [320780]
Mr. Mike O'Brien: A significant part of the Department's assessment of national health service foundation trust applications is the consideration of the quality of care provided at each organisation. This review of quality includes an explicit consideration of hospital standardised mortality rates, alongside other care quality indicators such as patient surveys and safety indicators.
Since April 2009 the Department's assessment has also included the consideration of each application by the NHS Medical Director. His satisfaction with an organisation is required prior to Ministers considering whether to support a foundation trust application. The NHS Medical Director considers a range of quality related intelligence, including hospital standardised mortality rates, in forming his view on each trust.
Mr. Stephen O'Brien: To ask the Secretary of State for Health what estimate he has made of the total cost of backlog maintenance in respect of (a) high, (b) significant, (c) moderate and (d) low risk in (i) England and (ii) each NHS organisation according to data from Estates Return Information Collection returns in each financial year from 1997-98 to 2008-09. [318225]
Mr. Mike O'Brien: The information is not available in the format requested.
Levels of backlog maintenance categorised by risk were not collected prior to 2004-05. The information relating to each national health service organisation from 2004-05 onwards has been placed in the Library.
Total cost of backlog maintenance cost for England, categorised by risk, is in the table.
£ million | |||||
Backlog maintenance | |||||
Risk level | 2004-05 | 2005-06 | 2006-07 | 2007-08 | 2008-09 |
The Department collects data on backlog maintenance annually from NHS trusts through its estates return information collection. These data have not been amended centrally and their accuracy is the responsibility of the contributing NHS organisations.
NHS organisations are locally responsible for the provision and maintenance of their facilities. This includes planning and investment to reduce backlog maintenance.
The Government have introduced 100 new hospital schemes which have increased capacity and provided the opportunity to reduce backlog maintenance.
Next Section | Index | Home Page |